RenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th
RenovoRx today announced it will participate in a JonesTrading webinar with oncology key opinion leaders (KOLs) and Shaun Bagai, Chief Executive Officer of RenovoRx, on August 13, 2026 at 1:30 p.m. ET.
Winship Offers TAMP™ Therapy Platform for Locally Advanced Pancreatic Cancer
Winship Cancer Institute of Emory University now offers TAMP™ therapy for patients with locally advanced pancreatic cancer, using RenovoRx’s FDA-cleared RenovoCath® device.